Related references
Note: Only part of the references are listed.C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study
Wolfgang Ries et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Prognostic significance of troponin level in 3121 patients presenting with atrial fibrillation (The NIHR Health Informatics Collaborative TROP-AF study)
Amit Kaura et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Invasive versus non-invasive management of older patients with non-ST elevation myocardial infarction (SENIOR-NSTEMI): a cohort study based on routine clinical data
Amit Kaura et al.
LANCET (2020)
Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome A Secondary Analysis of the VISTA-16 Trial
Preethi Mani et al.
JAMA CARDIOLOGY (2019)
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Association of troponin level and age with mortality in 250 000 patients: cohort study across five UK acute care centres
Amit Kaura et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Optical coherence tomography and C-reactive protein in risk stratification of acute coronary syndromes
Francesco Fracassi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
Paul M. Ridker et al.
LANCET (2018)
Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions
Deborah N. Kalkman et al.
EUROPEAN HEART JOURNAL (2018)
Has the time finally come to measure hsCRP universally in primary and secondary cardiovascular prevention?
Paul M. Ridker et al.
EUROPEAN HEART JOURNAL (2018)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Relationship Between Infarct Size and Outcomes Following Primary PCI Patient-Level Analysis From 10 Randomized Trials
Gregg W. Stone et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Misdiagnosis of Myocardial Infarction Related to Limitations of the Current Regulatory Approach to Define Clinical Decision Values for Cardiac Troponin
Karin Wildi et al.
CIRCULATION (2015)
Correlation of concentrations of high-sensitivity troponin T and high-sensitivity C-reactive protein with plaque progression as measured by CT coronary angiography
Harald Seifarth et al.
JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY (2014)
Comparison of the Framingham and Reynolds Risk Scores for Global Cardiovascular Risk Prediction in the Multiethnic Women's Health Initiative
Nancy R. Cook et al.
CIRCULATION (2012)
Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays
Fred S. Apple et al.
CLINICAL CHEMISTRY (2012)
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
Daniel I. Swerdlow et al.
LANCET (2012)
C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction
Stephen Kaptoge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A Prospective Natural-History Study of Coronary Atherosclerosis.
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data
Frances Wensley et al.
BRITISH MEDICAL JOURNAL (2011)
Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: Results from the MONICA/KORA Augsburg cohort study, 1984-1998
Wolfgang Koenig et al.
CLINICAL CHEMISTRY (2008)
C-reactive protein in patients with acute coronary syndrome: Correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings
Natale Daniele Brunetti et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2006)
Mechanisms of disease - Inflammation, atherosclerosis, and coronary artery disease
GK Hansson
NEW ENGLAND JOURNAL OF MEDICINE (2005)
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
PM Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)